Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors

Preview text: Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of…

Thursday, Sep 10, 2026 at 4:30 AM EasternMailchimp

Rakovina TherapeuticsRakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors

Fit to screenFull size

Using this email in an article? Credit: Rakovina Therapeutics email via They Sent It, with a link to this page. Full-size image

Use this example

Subject: Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
Preview text: Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of…
From: ir@rakovinatherapeutics.com
Brand: Rakovina Therapeutics
ESP: Mailchimp
Sent: Thu Sep 10, 2026, 4:30 AM ET
Size: 74 KB
Images: 7
Links: 11, 3 of them buttons
Subject length: 97 characters

Against Rakovina Therapeutics's usual

Sent in the 4 AM hour, which holds 19% of its emails; 31% arrive in the 4 PM hour. The subject is 97 characters; its average is 70.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Rakovina Therapeutics <[email protected]>
Reply-To: Rakovina Therapeutics <[email protected]>
Subject: Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
Date: Thu, 10 Sep 2026 08:30:53 +0000
Message-ID domain: mail93.atl301.rsgsv.net
Return-Path domain: mail93.atl301.rsgsv.net
DKIM signature: d=mailchimpapp.net s=k3
List-Unsubscribe: Present, one-click
Mailer: Mailchimp Mailer
Feedback-ID sender: mc

Other sending headers (names only): X-Campaign, X-campaignid, X-Report-Abuse, X-MC-User, X-Accounttype

	Oct 15, 2026 10:30 AM	Rakovina secures exclusivity on kt-5000 target profile
	Oct 1, 2026 4:18 PM	Rakovina partners with Celvion: what it means for our ATR program
	Sep 17, 2026 4:45 AM	Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
	Sep 10, 2026 4:30 AM	Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors (this email)
	Aug 31, 2026 7:00 PM	Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
	Aug 31, 2026 4:42 PM	Rakovina Therapeutics Announces Final Closing of Upsized Non-Brokered Private Placement
	Aug 19, 2026 7:01 AM	Rakovina Therapeutics Announces Results from 2026 Annual General Meeting